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Summary
Histocompatibility in the primitive chordate, Botryllus
schlosseri, is controlled by a single, highly polymor-
phic locus, the FuHC. By taking a forward genetic ap-
proach, we have identified a locus encoded near the
FuHC, called fester, which is polymorphic, polygenic,
and inherited in distinct haplotypes. Somatic diversifi-
cation occurs through extensive alternative splicing,
with each individual expressing a unique repertoire
of splice forms, both membrane bound and potentially
secreted, all expressed in tissues intimately associ-
ated with histocompatibility. Functional studies, via
both siRNA-mediated knockdown and direct blocking
by monoclonal antibodies raised against fester, were
able to disrupt predicted histocompatibility outcomes.
The genetic and somatic diversity, coupled to the ex-
pression and functional data, suggests that fester is
a receptor involved in histocompatibility.
Introduction
The major histocompatibility complex (MHC) and the
rearranging antigen receptors (immunoglobulins and
T cell receptors), which are key components of the adap-
tive immune system, have been described in all verte-
brates, but enigmatically, direct orthologs of these genes
have not been identified in more primitive organisms
(Flajnik et al., 2003). However, nearly all invertebrate
metazoans have highly effective tissue recognition sys-
tems with the ability to discriminate between multiple
alleles, a fundamental characteristic of adaptive immu-
nity. This functional relationship suggests that inverte-
brate histocompatibility systems may contain the evolu-
tionary precursors of vertebrate immunity; however, the
molecular mechanisms that underlie the ability to distin-
guish self from nonself in these invertebrate taxa are
poorly understood (Flajnik et al., 2003). The study of al-
lorecognition in the protochordates, immediate ances-
tors to the vertebrates, may therefore offer insight into
the evolution of tissue recognition systems and poten-
tially the origins of innate and adaptive immunity in the
vertebrates.
Botryllus schlosseri is a marine protochordate that
has been used as a model organism for studies on histo-
*Correspondence: tdet@stanford.educompatibility for more than 40 years (Oka and Wata-
nabe, 1960; Sabbadin, 1962; Scofield et al., 1982). B.
schlosseri begins its life as a free-swimming tadpole
larva with a chordate body plan, including a notochord,
dorsal hollow nerve tube, and striated musculature. Af-
ter hatching, the tadpole swims to a nearby surface,
attaches to the substratum, and undergoes metamor-
phosis into an invertebrate form (called an oozooid). In
addition, B. schlosseri is a colonial organism, and this
initial metamorphosis is followed by a budding process
that eventually gives rise to a large colony of asexually
derived, genetically identical offspring (zooids) united
by a common vascular network and embedded in a ge-
latinous coat, called a tunic (Rinkevich, 2002).
When two B. schlosseri colonies grow close together,
terminal projections of their vasculatures, called ampul-
lae, reach out and interact. This natural transplantation
reaction will result in either a vascular fusion, which cre-
ates a chimeric colony sharing a common blood supply,
or a rejection reaction, which is a blood-based inflam-
matory reaction during which the interacting ampullae
are destroyed, preventing blood transfer. Fusion or re-
jection is governed by a single highly polymorphic locus
called FuHC (for fusion and histocompatibility). Colonies
sharing a single (or both) alleles of FuHC will fuse, while
colonies sharing neither of the alleles will reject (Oka and
Watanabe, 1960; Sabbadin, 1962; Scofield et al., 1982).
Functionally, this mechanism resembles the ‘‘missing
self’’ mode of effector function described in vertebrate
Natural Killer (NK) cells, with the exception that rejection
is blocked by the presence of a single self allele (Ka¨rre
et al., 1986).
A candidate FuHC histocompatibility ligand has been
identified (De Tomaso et al., 2005). However, the effector
mechanisms controlling allorecognition remain unknown.
During physical mapping of the FuHC locus, a gene
tightly linked to the FuHC was identified, which we
have named fester, and it contains a short consensus
repeat (SCR, or sushi) domain found often in vertebrate
complement receptors. Here we describe isolation,
characterization, and functional analysis of fester, and
the data suggest that fester may represent an allorecog-
nition receptor outside the vertebrates.
Results
Isolation of fester
During positional cloning of the FuHC locus, a BAC clone
(SuBsB 2j9; De Tomaso and Weissman, 2003) 200 Kb
from the candidate FuHC was sequenced. A 186 bp re-
gion was identified that encoded an open reading frame
with homology to a short consensus repeat (SCR), or su-
shi domain, a conserved domain found predominantly in
complement receptor proteins and selectins. 50 and 30
rapid amplification of cDNA ends (RACE) from primers
designed to this region identified a 2.3 Kb cDNA, which
we called fester. The cDNA predicted a 368 residue pro-
tein with a predicted type I membrane protein topology,
containing a putative signal sequence and three tandem
transmembrane domains (Figure 1A). Besides the SCR
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164Figure 1. Diversity of the fester Alleles at the Protein, Nucleotide, and Genomic Levels
(A) Amino acid sequence and exon structure of a full-length A clade fester gene is shown, as well as the exon encoding the secreted forms of
the protein. The SCR homologous region is represented by exon 5 (blue). The transmembrane domains are shown in exons 8, 9, and 10 (bolded).
Amino acids created by different splice forms are indicated by asterisks.
(B) Amino acid alignments from all 21 fester alleles. A portion of the extracellular region is shown, consisting of 90 amino acids, and grouped into
three clades.
(C) Pip analysis of three fester gene family members from an F2 mapping cross. BAC and fosmid clones corresponding to the three fester loci
(A, B1, B2) were cloned and sequenced. Two fester loci (A, B-2) were compared to a third (B-1) by PIP analysis and results are shown graphically.
The pink areas are regions of homology greater than 75% identical between all three genomic clones, the green areas are greater than 50%
identical, and the white areas are less than 50% identical. The genomic region spanning the fester gene is shown (horizontal arrow). Analysis
of the loci also revealed that a gene with homology to a HECT-domain containing E3-ubiquitin ligase was encoded adjacent to each fester locus
in both haplotypes.
(D) PAUP analysis of the nucleotide sequence of fester alleles grouped into three distinct clades (A, B, and C). Line represents five nucleotide
changes between sequences.domain, the full-length protein has no strong homology
to any proteins in the database, including those from
the complete genome sequences of a related ascidian
(Dehal et al., 2002; Azumi et al., 2003). Nor does this pro-
tein have any recognizable signaling or other notable
motifs.
The cDNA corresponded to a gene encoding 11 exons
spanning 45 Kb, with the first seven exons encoding the
majority of the extracellular domain and the next three
exons (exon 8–10) encoding each of the three predicted
transmembrane domains. The eleventh and final exonencodes a short intracellular tail and a large 30 untrans-
lated region of 1.5 Kb (Figure 1A).
Comparison of cDNA to genomic sequence also re-
vealed that the fester gene was highly polymorphic.
Over the entire coding region, the cDNA was on average
98% identical to the genomic clone, but 75% of the nu-
cleotide changes were nonsynonymous, changing an
amino acid. These changes were concentrated in the
putative extracellular domain, and these polymorphisms
were further analyzed in cDNA from both laboratory-
reared and natural populations (see below).
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was also discovered. PCR reactions from different
B. schlosseri individuals showed a varying number of
smaller cDNAs that were amplified along with the original
full-length cDNA. Sequencing of these smaller cDNAs
revealed that they encoded a number of alternatively
spliced variants of full-length fester. Each B. schlosseri
individual (both from mapping crosses and wild-type)
expressed at least eight different alternatively spliced
variants. This alternative splicing is mainly in the pre-
dicted extracellular domain and occurs such that each
individual analyzed contains a set of cDNAs with differ-
ent extracellular exon combinations. The vast majority
of these variants were combinations of splicing of exons
6 and 7, and occasionally with exons 2, 3, and 5 (Fig-
ure 1A). Exons in all splice variants continued to encode
the same protein sequence, without frameshifts.
In addition, there were also common splice variants in
the 30 end of the gene that changed the C terminus of
the fester protein. First, putative secreted forms were
created by splice variants removing exons 8–11 and
the addition of a new exon (exon 12, Figure 1A), which
encoded two amino acids and a 250 bp 30 UTR. Exon
12 is adjacent to exon 11 in the genome but is unique
to the secreted form and not seen in any variants encod-
ing exons 8–11. The putative secretory splice forms of
the protein are also quite diverse and include variants
in the earlier exons (3–7), and thus each individual poten-
tially secretes a diverse repertoire of fester proteins.
There were also common transmembrane splice vari-
ants with combinations of exons 9 and 10, including
8-9-10-11 (full-length), 8-9-11, 8-10-11, or 8-11 on the
30 end of the gene. Splice variants without exon 8 (en-
coding the first TM domain) or 11 (the C-terminal tail of
the protein) were not seen. We have established that
exon 8 encodes a functional transmembrane domain
(Figure 1A; Figure S1 in the Supplemental Data available
with this article online); however, if the predicted trans-
membrane domains encoded by exons 9 and 10 are
real, any splice forms of these exons would change the
topology of the protein, moving the intracellular tail (en-
coded on exon 11) from the inside of the cell to the out-
side, and in the case of the last splice variant (8-10-11),
would result in inverting the potential transmembrane
domain on exon 10, sending it through the membrane
in the reverse orientation. Whether the topology of the
fester protein can be that flexible is unknown. However,
as observed with the secreted variant, these C-terminal
splice variants were found multiple times, with differing
combinations of extracellular exons 3–7.
In total, we identified 36 potential splice variants (a
combination of splicing of exons 3, 5, 6, 7, 9, 10, plus
the secreted exon 12), with 24 of these being observed
frequently (variants containing combinations of exons
5 and 6 coupled to combinations of exons 7–12). Al-
though not analyzed quantitatively, sequencing of multi-
ple clones from RT-PCR reactions from individuals
always revealed a varying number and type of splice
variants, with a minimum of 16. Thus, each individual ap-
pears to express both the full-length fester gene, plus
an individual-specific subset of alternatively spliced var-
iants, encoding proteins with different extracellular and
intracellular coding regions, as well as putative secreted
forms. Genomic analysis (discussed below) revealedthat all variants were encoded by a single locus within
the B. schlosseri genome.
Genetics and Genomics
Initially, the overall polymorphism of fester in natural
populations was assessed. Four to six individuals each
were collected from harbors along the California coast,
from San Diego in the south to Half Moon Bay in the
north, and the extracellular region of festerwas amplified
and sequenced from each individual. 21 fester alleles
(Figure 1B) were identified, of which 7 alleles were found
in multiple individuals and 14 alleles were each identified
only in a single individual. The alleles were highly diver-
gent, with an average of 75% of the nucleotide changes
being nonsynonymous between any two sequences.
Phylogenetic analysis grouped the alleles into three dis-
tinct clades (Figures 1B and 1D), which we called the A,
B, and C clade, respectively. Alleles from A and B clades
were found in all populations sampled and also corre-
sponded to the clones from our lab-reared strains: BAC
clone 2j9 was a B clade gene, whereas the first cDNA
was A clade. Studies of wild-type populations also re-
vealed that individuals expressed either A clade only,
B clade only, or both A and B clade fester genes. In addi-
tion to A and B clades, two individuals also expressed
C clade alleles, alluding to further diversity.
Next, the genetics of the fester gene were analyzed by
sequencing of individual exons and cDNAs from individ-
uals in our main F2 mapping cross with FuHC-defined
strains (designated FuHC AA x FuHC BY; Table 1; De
Tomaso and Weissman, 2003). These analyses revealed
that the FuHC AA and FuHC YY homozygous individuals
contained a single, shared, festerA clade allele, whereas
the FuHC BB individual contained two fester B clade al-
leles (B-1, B-2). We concurrently screened 13X coverage
BAC and Fosmid libraries, which had been made from
F2 individuals from this same cross (De Tomaso and
Weissman, 2003). Out of eight new clones, we identified
three independent loci encoding the three alleles. The
original BAC 2j9 clone belonged to the B-1 class, and
genomic clones containing the A and B-2 alleles were
sequenced. Nucleotide differences between these three
loci allowed us to follow the segregation of each allele
independently (Table 1). These results demonstrated
that all three loci are linked to the FuHC locus and con-
firmed the above results that the FuHC A and FuHC Y
haplotype both have a single A clade fester locus with
identical alleles, whereas the FuHC B haplotype has
two linked fester loci (B-1 and B-2).
The distribution of the clade-specific genetic markers
in nine of the wild-type individuals shown in Figure 1 was
analyzed (Table 2). In all individuals expressing B clade
cDNA, both B-1 and B-2 genetic markers were identi-
fied, and in all individuals expressing A clade cDNA,
A-specific genetic markers were identified. Importantly,
individuals homozygous for A clade fester never had B-1
or B-2 genetic markers, and individuals homozygous for
B clade fester never contained the A genetic markers.
This was exactly as seen for mapping cross individuals
(Table 1), and thus the two distinct fester haplotypes
appeared to be a population level phenomenon, and
all loci are linked to the FuHC. In addition, all inherited
alleles were expressed. These results also eliminated
the possibility that fester polymorphisms play a role in
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a fester A allele but were not histocompatible, in direct
contrast to the rules of FuHC-based allorecognition.
Large-scale sequence comparisons of the B-1 geno-
mic clone to the other two loci were done via percent
identity plot (PIP) analysis (Schwartz et al., 2000) and
revealed that although the fester exons are conserved,
regions around the gene (and even within different in-
trons) are highly divergent (Figure 1C). The two B clade
loci seem to be closely related across the fester gene,
but any homology drops off on each side of the locus.
festerdiversity is therefore generated in multiple ways.
In addition to the medley of alternative splice forms
found at the level of the individual, B. schlosseri popula-
tions express at least 21 different alleles, and the com-
plexity of this diversity is broadened through the inheri-
tance of distinct fester haplotypes.
fester Expression
Expression patterns of fester were analyzed in both tad-
pole larvae and adults. In the adult, both full-length and
alternatively spliced forms of the expressed gene could
be found in cDNA isolated from adult blood and ampul-
lae via both RT-PCR (Figure 2A) and 30 RACE (Figure 2B).
All splice forms could also be isolated from cDNA made
from larvae at 6 days after fertilization (Figure 2B).
Localization of fester expression was further analyzed
in both the tadpole larvae and adults via whole-mount
in situ hybridization by means of a probe containing
the first three, unspliced exons (Figures 2C–2J) and via
whole-mount immunohistochemistry with a monoclonal
antibody generated to the A clade full-length fester pro-
tein (Figures 2K–2R; Figure S1). Developmentally, fester
was first observed about 4 days after fertilization in the
anterior end of the embryo (Figure 2C). In the tadpole,
expression of the fester gene was localized to an area
where the adult ampullae are forming and emerge during
metamorphosis, as well as in the adhesive papillae,
structures believed to be important in settlement (Fig-
ures 2D and 2K). The in situ data suggest that all splice
variants were coexpressed. In the adult, expression is
observed in the epithelial cells of the ampullae, as well
as cells that had migrated into the tunic, which covers
the entire individual (Figures 2E, 2F, 2L, and 2M). A subset
of blood cells was also found to express fester (Figures
2H and 2M) and appear to be either macrophages and/or
Table 1. fester Genetics Analyzed in FuHC AA x FuHC BY F2 Cross
FuHC Allele n fester Genomic Markers
Po AA 1 A
Po BY 1 A, B-1, B-2
F2 AA 3 A
F2 BB 1 B-1, B-2
F2 YY 2 A
F2 AB 32 A, B-1, B-2
F2 AY 44 A
F2 BY 3 A, B-1, B-2
The three fester genomic clones can be distinguished by nucleotide
polymorphisms detected via a PCR-RFLP approach (see Experi-
mental Procedures) and form three groups: A from the A clade and
B-1 and B-2 from the B clade alleles (see text). Parental (Po) and
adult F2 generation individuals were tested, and the results are
shown. No recombination occurred between fester and FuHC, nor
between the two B clade fester loci.signet ring cells, although there is heterogeneity in ex-
pression even within these broad classifications of cells,
e.g., not all signet ring cells express the protein (Hirose
et al., 2003). Morula cells, a distinctive blood cell type
in B. schlosseri, did not appear to express the gene
(Figure 2H, lower arrow). However, it is difficult to more
precisely delineate expression to a particular subset of
blood cells in Botryllus, as little is known about their
structure and development at this point, and there are
no other robust molecular markers for comparison (Hir-
ose et al., 2003). As a control for these experiments,
a monoclonal antibody developed to whole Botryllus
homogenates that recognizes the tunic (H. Boyd and
I.L.W., unpublished data) positively labeled the exterior
of tadpoles as well as metamorphosed adults (Figures
2N–2P). No labeling was seen with secondary antibody-
alone controls (Figures 2Q and 2R). These data therefore
show that fester proteins are expressed temporally and
spatially in tissues involved in FuHC-based allorecogni-
tion. Importantly, the in situ and immunofluorescence
data were identical, suggesting that all splice variants
show the same broad temporal and spatial expression
patterns.
fester Function
To analyze fester function, we used two techniques:
siRNA to knockdown protein expression during experi-
mentally induced vascular regeneration, and acute inter-
ference of the reaction with the mAb generated against
the expressed fester protein. For the former, we have
previously shown that protein expression can be com-
pletely knocked down by soaking or injecting individuals
with siRNA (Laird et al., 2005a). Furthermore, we have re-
cently found that the entire peripheral vasculature of this
animal can be dissected away and will regenerate within
72 hr after surgery (Figures 3A–3C; A.V., S.V.N., K. Ishi-
kuza, I.L.W., and A.W.D., unpublished data). Because
these new ampullae are replacing fester proteins, this
allowed us the opportunity to block expression during
regeneration. A series of experiments were designed
to use this surgical procedure, called ampullaectomy,
in conjunction with a RNAi-mediated knockdown of
fester expression to test these effects on histocompati-
bility outcomes in fusing and rejecting colonies (Table 3).
Ampullae were surgically removed, and colonies were
injected or soaked with siRNA-targeting fester, or as a
control, to GFP. fester expression could be completely
knocked out by this system as assayed by immunofluo-
rescence microscopy for up to 5–6 days after siRNA
treatment (Figures 3D and 3E). Between 5 and 7 days af-
ter treatment, fester expression returned to normal (not
Table 2. PCR-RFLP Distribution in fester-Defined Wild-Type
Colonies
fester cDNA Allele Clade n fester Genomic Markers
A 2 A
B 3 B-1, B-2
A + B 4 A, B-1, B-2
Genomic and cDNA from nine wild-type individuals were isolated
and fester alleles genotyped by sequencing multiple (48–96) individ-
ually picked cDNA clones and by PCR-RFLP analysis as described
in the text. The genomic markers correspond exactly to cDNA
expression.
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(A) The full-length fester gene amplified from adult blood, ampullae, and total colony as well as from tadpole larvae via RT-PCR.
(B) Same as (A) via 30-RACE.
(C–J) In situ hybridization of embryos and juvenile animals are shown.
(C) Expression of fester was first observed approximately during day 4 of embryogenesis at the anterior end of the developing embryo (blue
staining).
(D) Upon release of the tadpole larvae, fester mRNA expression was observed in the adhesive papillae and developing ampullae (blue staining,
arrow).
(E) 24 hr after metamorphosis, fester is seen on the epithelia of the vasculature wall and in blood cells in the tunic.
(F) A closer view of the expression in the ampullae from (E).
(G) Sense control in the tadpole.
(H) In situ hybridization through sectioned ampullae reveal a subset of fester-expressing blood cells. The positive cell in this view is likely a
macrophage. Three morula cells, also visible in this micrograph, do not appear to express fester.
(I) In situ hybridization of blood cells with an antisense probe to actin used as a positive control.
(J) In situ hybridization of blood cells with a sense probe as a negative control.
(K–R) Whole-mount immunohistochemistry (IHC) showing fester protein expression. Monoclonal antibodies against the fester protein were
generated and used to localize expression in tadpole and metamorphosed adults. Secondary detection is shown in red. Nuclei are stained
with DAPI (blue).
(K) During settlement, fester expression was detected in the developing ampullae (amp).
(L) In the adult body, fester is expressed in epithelium of the ampullae.
(M) A close-up of an ampulla also reveals expression in a subset of the blood cells (bc), tunic cells (tc), and epithelial cells (ec) that line the
ampullae.
(N) IHC of tadpole with a positive control monoclonal antibody previously generated from wholeBotryllus cell homogenates. This antibody binds
the tunic (H. Boyd and I.L.W., unpublished data).
(O) Positive control IHC of metamorphosed juvenile with antibody from (N). The tunic (t) is stained in red. The body of the zooid (blue) and
ampullae do not react with this antibody (gaps, arrows).
(P) Same image as in (O) showing antibody bound to tunic with no DAPI staining. Ampullae appear as unstained gaps (arrows).
(Q) Secondary antibody alone, adult body plan.
(R) Secondary antibody alone, tadpole.
Abbreviations: amp, ampullae; bc, blood cell; t, tunic; tc, blood cell that has migrated into the tunic; ap, adhesive papillae; en, epithelial cell of the
ampullae.shown). In contrast, siRNAs designed to GFP had no
effect on fester expression versus untreated controls,
and normal fester expression was seen upon the com-
pletion of ampullar development, 48–72 hr after surgery(Figures 3F and 3G). If the ampullaectomy was not per-
formed, fester siRNA treatment did not noticeably affect
fester expression on the unmanipulated ampullae as as-
sayed by immunofluorescence (not shown), suggesting
Immunity
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(A–H) The ampullaectomy assay and siRNA are shown. Ampullaectomies were performed on colonies, removing the entire peripheral vasculature
concurrent with siRNA treatment (see Experimental Procedures).
(A) View of a colony before ampullaectomy; red color in bottom two zooids is phenol red coinjected with the siRNA.
(B) A system from the same colony immediately after ampullaectomy; vasculature has clotted, preventing bleeding.
(C) 24 hr after ampullaectomy, small regenerated ampullae appear along the periphery of the colony (white arrow). Colonies fully regenerated
their ampullae within 72 hr after surgery.
(D) DIC image of a regenerated ampulla that was treated with fester siRNA.
(E) Same ampulla observed under fluorescence after staining for immunohistochemistry with the mAb generated against fester, expression is
completely knocked down under these conditions.
(F) A DIC image showing regenerated ampullae that received treatment with GFP siRNA as a control.
(G) Same ampullae showing fester expression, 72 hr after ampullaectomy (green).
(H) fester siRNA-treated colonies. These are compatible colonies 80 hr after physical engagement of the regenerated ampullae. These colonies
did not fuse for another 2.5 days. However, control colonies that received ampullaectomies but were either untreated or treated with GFP siRNA
fused between 24 and 48 hr after ampullar contact (n = 3; Table 3), a time frame representative of a normal wild-type fusion. To show that siRNA
treatment affected fester expression, colonies were given ampullaectomies and were either treated or untreated with siRNA during the regen-
eration process (Table 3). Colonies were then prepared for immunohistochemistry and fester expression was observed with an allele-specific
fester monoclonal antibody.
(I–K) Injection of fester mAbs affected histocompatibility in rejecting, but not fusing, genotypes (also see Table 4).
(I) Two incompatible genotypes were placed in a histocompatibility assay.
(J) 24 hr after ampullar contact, the colonies rejected, leading to melanization and points of rejection (circle).
(K) The same rejecting genotypes were each injected with approximately 0.1 mg of purified fester monoclonal antibody. 24 hr after injection, some
ampullae had fused (arrows), while other were in the process of rejection (circles). In other experiments, all ampullae fused (n = 3; Table 4).
Rejecting colonies injected with either filtered seawater or a control mAb that recognizes the tunic (n = 3; Table 4) never fused.that fester turnover is on the order of days under normal
conditions.
Individual colonies were subjected to ampullaectomy
and siRNA treatment and placed in contact, and histo-
compatibility outcomes were assayed for both fusing
and rejecting phenotypes (Table 3). For compatible
pairs, fester siRNA-treated colonies became unreactive:
i.e., they had ampullar contact for up to 6 days with no
fusion reaction (Figure 3H). On day 7, normal fusion
would occur, concurrent with increased expression of
fester. In contrast, control colonies with siRNA-targeting
GFP fused within 24 hr after ampullar contact (which
occurs 60–72 hr after surgery), the normal time frame
for histocompatibility reactions (Table 3).Knockdown of fester in FuHC-incompatible colonies
also prevented rejection reactions (Table 3): analogous
to compatible interactions, ampullar contact was made
for up to 5 days before a phenotypic rejection reaction
occurred, which was coincident with reexpression of fes-
ter (not shown). In contrast, control subclones showed
normal rejection responses within 24 hr (Table 3). In sum-
mary, blocking fester expression appeared to block initi-
ation of the histocompatibility reaction, because in both
histocompatible and nonhistocompatible settings the
ampullae would touch, but no reaction would take place
until fester expression reappeared. Finally, if the ampul-
laectomy was not performed, fester RNAi treatment
would not affect either fusion or rejection (Table 3). These
fester, a Candidate Allorecognition Receptor
169Table 3. Inhibitory RNA Injections
Colonies Control Fuse or Reject n Ampullaectomy RNAi Target
RNAi Outcome
Fuse or Reject
HM9aYw1225/self fuse 3 no fester fuse
HM9aYw1225/self fuse 3 yes gfp fuse
HM9aYw1225/self fuse 3 yes fester no reaction
HM9aYw1225/SC27f fuse 3 yes fester no reaction
HM9aYw1225/ML6g reject 3 no fester reject
HM9aYw1225/ML6g reject 3 yes gfp reject
HM9aYw1225/ML6g reject 3 yes fester no reaction
RNAi coupled to ampullar regeneration was carried out as described in the text. Colonies with known fusion or rejection outcomes were picked
and subjected to RNAi-mediated fester knockout during the presence or absence of surgically induced vascular regeneration (ampullaectomy).
siRNA from GFP was also used as a control for two of the colony pairs (HM9aYw1225/self and HM9aYw1225/ML6G).experiments suggested that fester is involved in initiation
of allorecognition, i.e., fester is an activating receptor
that functions to alert the colonies that they are in contact
with another individual.
Concurrently, we tested the ability of our mAb to affect
histocompatibility reactions (Figures 3I–3K; Table 4).
Colony pairs with known fusibility outcomes were in-
jected with either A clade mAb, an isotype-matched
control mAb (see Experimental Procedures), or sea wa-
ter (FSSW). Colonies were then brought into contact and
histocompatibility outcomes were visually assessed.
With histocompatible colonies, the injection of fester
mAb, or a control antibody, did not inhibit or alter the
ability of those colonies to fuse regardless of the fester
allele that either genotype carried (Table 4). However,
mixed results were seen in rejecting colonies. If both col-
onies where heterozygotes (expressing both A and B
clade alleles), then the fester antibody had no visible af-
fect on the histocompatibility outcome (Table 4; 1800a/
1822a). However, when one of the colonies in the reac-
tion was homozygous for fester A clade alleles and
the other was heterozygous (Table 4; colony 1736e/
1797d), injection of the fester antibody caused the two
noncompatible colonies to fuse within 48 hr after injec-
tion (Table 4, Figure 3K). In one of these trials, both fu-
sion and rejection were seen at different contact points
along the interacting surfaces (Figure 3K). In contrast,noncompatible colonies injected with the control anti-
body or with filtered sea water rejected each other nor-
mally (Table 4; 1800a/1822a and 1736e/1797d). This
result shows that Mab interaction with fester protein
can convert a rejection to a fusion or fusion/rejection
along a surface of interacting ampullae; this occurred
only in a situation wherein fester AA and AB clades
were involved. While this shows that fester allelic pro-
teins involved in the cascade of events leading to rejec-
tion can be disrupted by Mab binding, several possible
mechanisms could explain this result (Table 4). Unfortu-
nately, we were unable to find wild-type individuals that
both rejected each other and were homozygous for each
haplotype. Nevertheless, these results demonstrate an
allele-specific change in histocompatibility outcomes
in vivo.
In summary, both functional assays demonstrate that
fester is involved in allorecognition responses. Under
the acute setting of mAb blocking, fusion reactions
were unaffected, but rejection reactions were altered to
fusions in an allele-dependent manner. But under fester
knockdown, the histocompatibility reaction appeared to
be blocked at the stage of initiation and affected both
fusion and rejection reactions similarly, as if the colonies
were unaware they were involved in a reaction. Together,
the data suggests that fester plays multiple roles during






HM9aYw1225/self 3 fusion FSSW fusion AB/AB
HM9aYw1225/self 2 fusion tunic (7A10) fusion AB/AB
HM9aYw1225/self 5 fusion fester (5B1) fusion AB/AB
HM9aYw1225/ML6g 2 rejection fester (5B1) rejection AB/BB
1225c/self 1 fusion fester (5B1) fusion AA/AA
1800a/1823f 2 fusion fester (5B1) fusion AB/nt
1800a/1966c 2 fusion fester (5B1) fusion AB/nt
1800a/1822a 2 rejection FSSW rejection AB/AB
1800a/1822a 3 rejection tunic (7A10) rejection AB/AB
1800a/1822a 3 rejection fester (5B1) rejection AB/AB
1736e/1797d 2 rejection FSSW rejection AA/AB
1736e/1797d 3 rejection tunic (7A10) rejection AA/AB
1736e/1797d 3 rejection fester (5B1) fusion AA/AB
Antibodies were administered to fusing and rejecting colonies as described in the text. Both injections of filtered sea water (FSSW) and an
isotype-matched, anti-tunic antibody (see Experimental Procedures) were used as controls. Nine different laboratory-reared colonies
(HM9aYw1225; ML6G; 1225c; 1800a; 1823f; 1822a; 1966c; 1736e; and 1797d) were used for the treatments. cDNA from each colony was analyzed
to determine expressed fester alleles. nt, not tested. Bold text indicates experiments where fester antibody converted a rejection into a fusion.
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This study describes the isolation and characterization
of fester, a candidate allorecognition receptor linked to
the highly polymorphic FuHC histocompatibility ligand.
Multiple lines of evidence suggest that fester plays
a role in allorecognition. First, fester has a key character-
istic of immune-related loci: diversity. Initial sampling
along the California coast identified 21 alleles from 30
individuals, and there is an unusually high nonsynony-
mous/synonymous substitution ratio among them, sug-
gesting selection for divergent alleles. There is also indi-
vidual-specific somatic diversification achieved via
alternative splicing. Splice forms with differing combina-
tions of nearly every exon, with the exceptions of 1, 2,
and 4, have been observed. While not yet done quantita-
tively, multiple sequences from individual PCR amplifi-
cations (24–96/individual) always show a unique number
and array of both membrane bound and putative se-
creted splice forms. Finally, the genetic linkage of fester
and the FuHC suggests the maintenance of allorecogni-
tion function via coevolution of these loci.
fester expression patterns also suggest their involve-
ment in allorecognition. In the adult, expression of all
splice forms is restricted to the ampullar epithelia, as
well as a subset of blood cells. fester expression is also
seen in the developing embryo, and this result is very im-
portant because the oozooid of B. schlosseri is compe-
tent to undergo theFuHC-based histocompatibility reac-
tion immediately after metamorphosis (Scofield et al.,
1982). Thus, any genes involved in histocompatibility
must be expressed by this time. Furthermore, the effec-
tor system involved in discriminating between multiple
FuHC alleles is likely undergoing education processes,
and this would take place in a period between concep-
tion and hatching/metamorphosis (discussed below).
Spatial expression patterns of the FuHC gene are identi-
cal to fester during tadpole development (De Tomaso
et al., 2005).
When two Botryllus individuals come into contact,
they undergo a natural transplantation reaction. If they
share one or both alleles at a single, highly polymorphic
histocompatibility locus, the FuHC, they will fuse their
vasculatures and create a blood-based chimera. If they
share no alleles, the colonies will reject each other, pre-
venting blood transfer. This highly polymorphic allore-
cognition system likely exists to strictly limit the possibil-
ity of fusion, as stem cells in blood-based chimeras can
move from one individual to the next, and once trans-
planted, these stem cells are in competition for contribu-
tion to the germline (Sabbadin and Zaniolo, 1979; Stoner
et al., 1999; Laird et al., 2005b). Usually one cell type wins
and only one genotype is represented in the gametic
output of both individuals. The ability to parasitize is a
repeatable and heritable trait (Stoner et al., 1999), and
these parasitic abilities are autonomous to the stem cells
themselves, as they can be prospectively isolated and
retain their phenotype upon experimental transplanta-
tion (Laird et al., 2005b). To counteract this genetically
controlled stem cell parasitism, natural populations
show extraordinary polymorphism at the FuHC locus,
essentially limiting fusion to kin, lowering the evolution-
ary costs of parasitism (Buss, 1987). Rejection precludes
chimerism, and the species is saved from genetic ho-mogenization by competitive germline lineages, which
do exist in nature (Stoner et al., 1999; Laird et al., 2005a).
Given this essential function, how can a primitive
chordate organism effectively discriminate between
hundreds of FuHC alleles? A priori, it is unlikely that
FuHC alleles could evolve to distinguish themselves
via only homotypic interactions, and therefore an effec-
tor system would exist that can correctly respond to
FuHC diversity. The rules of allorecognition in Botryllus
are that fusion occurs if only a single FuHC allele is
shared, so this system is clearly not directly responding
to nonself. In addition, there is no evidence of the com-
plex, genome-level somatic diversification mechanisms,
such as RAG-mediated recombination or AID-depen-
dent mutation, required for the creation of receptors
specific for each of hundreds of FuHC alleles, which
thus far have been identified only in the vertebrates (Flaj-
nik et al., 2003; Dehal et al., 2002; Azumi et al., 2003).
The rules of fusibility are reminiscent of those of verte-
brate NK cells, where the recognition of polymorphic de-
terminants on self MHC by nonrearranging receptors
can prevent a rejection reaction (Ka¨rre et al., 1986). We
hypothesize that in Botryllus embryos, the effector sys-
tem is educated to both self FuHC alleles and that the
presence of a single self allele in another colony pre-
vents a rejection reaction. However, this would be a sim-
plified version of the organization of vertebrate NK cells,
which occur in incompletely overlapping subsets, de-
fined by variegated expression of inhibitory NK recep-
tors, each specific for different self-MHC alleles (Lanier,
2005; Yokoyama and Plougasterl, 2003; Raulet et al.,
2001). Systemically, this heterogeneity can result in a re-
jection unless both alleles are shared (i.e., hematopoi-
etic histocompatibility; Yu et al., 1992), in contrast to
the situation in Botryllus. Nevertheless, the effector sys-
tem in Botryllus can clearly discriminate between hun-
dreds of FuHC alleles, and the underlying mechanisms
are likely to be conserved with other innate recognition
systems. For example, vertebrate NK effector education
is partly based on differential expression of nonrear-
ranging receptors (Raulet et al., 2001). The individual-
specific alternative splicing of fester extracellular domains
may be indicative of this type of education mechanism,
whereby expression of a unique repertoire of splice
variants creates an overall avidity to self FuHC mole-
cules that can contribute to this discriminatory ability.
While other receptors may exist, the overall genetic
and somatic diversity of fester coupled to expression
patterns would be predicted characteristics of a protein
involved in this process.
Functional data also indicate that fester plays key
roles in histocompatibility. Inhibiting expression of fes-
ter or blocking putative interactions with mAbs both
affect allorecognition outcomes, albeit with different re-
sults. mAb binding experiments suggest that in some
settings, antibody binding to fester can convert a rejec-
tion to a fusion. If the mAb blocked the interactions be-
tween an inhibitory receptor and its ligand, then we
hypothesize that opposite results should have been ob-
served, i.e., a fusion reaction should have been changed
to a rejection reaction, while incompatible colonies were
unaffected. Blockade of an activating receptor, or a re-
ceptor that initiates both activating or inhibitory recep-
tors, depending on coreceptor signaling, could convert
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ated genetic knockdown experiments suggested this
complicated scenario: that fester can also be an activat-
ing receptor involved in initiating a histocompatibility
reaction. Some differences in the functional outcomes
may be attributed to the procedures themselves; for ex-
ample, mAb binding is necessarily an acute treatment
delivered close to the initial physical interactions of the
allorecognition reaction, which may be after activation
occurs. Alternatively, if the mAb stimulated an activating
form of fester, it would have no affect on the outcome.
In contrast, siRNA treatment blocks expression of both
membrane and putative secretory forms of the protein
both before and after the ampullae come into contact,
blocking activation, which would then be followed by
a missing-self reaction. Clearly, details of the separate
roles of secreted and membrane forms of fester and of
putative coreceptors are needed before these issues
can be elucidated.
In vertebrate NK cells, effector responses are ulti-
mately governed by a complex interaction of both stim-
ulatory and inhibitory receptors (Lanier, 2005; Yokoyama
and Plougasterl, 2003; Raulet et al., 2001), and there is
evidence of an activation phase of FuHC-based allore-
cognition. There are a number of botryllid species, and
all of them studied to date have been shown to have sin-
gle-locus allorecognition systems (Saito et al., 1994), yet
typical rejection reactions are not normally observed
with xenogenic combinations: different botryllid species
will usually grow into and over each other and not react
to each other. However, there are exceptions: in three
xenogenic combinations, one species would show a typ-
ical rejection reaction, while the other would be unreac-
tive, as if it was not activated by the other species (Saito,
2003). Together this suggests the presence of a less
specific, species-level activation of allorecognition prior
to allelic discrimination. Our data imply that fester may
be involved in both initiating an allorecognition reaction
as well as subsequently playing a role in discriminating
polymorphisms to determine fusibility.
The ability to play multiple roles would require fester
to partition recognition (to stimulatory and inhibitory
ligands) and/or effector function. For recognition, there
is no immunological reason that the FuHC could not
be both a stimulatory and inhibitory ligand. In fact, the
FuHC has an alternatively spliced form encoding a puta-
tive secretory form of the protein that contains about
half of the normal ectodomain (and thus polymorphism)
of each allele and is expressed by the ampullae (De
Tomaso et al., 2005). Thus, colonies are likely communi-
cating prior to physical engagement, and this could ex-
plain a less discriminatory, species-specific activation
phase of histocompatibility. The idea that there is hu-
moral component to histocompatibility is also consis-
tent with previous studies on allorecognition in botryllid
ascidians (Tanaka, 1973; Sabbadin, 1962).
From an effector standpoint, we hypothesize that par-
titioning of activating and inhibitory functions of fester
could be accomplished by either alternative splice vari-
ants on a single population of cells conferring stimula-
tory or inhibitory signaling or by having separate popu-
lations of cells that differentially signal downstream
effector cells mediating either fusion or rejection. For
example, while fester has no recognizable intracellularsignaling domains, alternatively spliced exons 9 and
10, which encode predicted a helices, could create as-
sembly domains with specificity for different signaling
molecules. While the signaling pathways in Botryllus
histocompatibility are not known, this is reminiscent of
many vertebrate stimulatory receptors, which do not
have signaling domains, but instead associate with
adaptor molecules that do (Lanier, 2003). Alternative
splicing has also been shown to play a role in differential
signaling: isoforms of mouse NKG2D may confer differ-
ential association with the signaling adaptor molecules
DAP10 and DAP12, although this is likely to be more
complex than once thought (Rabinovich et al., 2006). In
summary, we hypothesize that extracellular splice vari-
ants, which occur in an individual-specific fashion, are
used to create an avidity that contributes to discriminat-
ing between both species-specific and individual-spe-
cific FuHC polymorphisms, while intracellular splice var-
iants partition activating and inhibitory function. In the
vertebrate NKC, phylogenetically related activating
and inhibitory receptors with the same ligand specificity
are proximally encoded (e.g., Ly49a and Ly49d forH2Dd;
Karlhofer et al., 1992; Nakamura et al., 1999); fester may
accomplish the same functions via alternative splicing.
Characterizing the distribution, function, and putative
binding partners of the different splice forms, as well
as identifying downstream signaling pathways, is an im-
portant goal.
Polymorphic residues of FuHC alleles predict histo-
compatibility outcomes by themselves (De Tomaso
et al., 2005), suggesting that they would be the ligands
blocked by mAb binding to fester. During the course of
these experiments, several direct binding assays be-
tween fester and the cFuHC were tried but were unsuc-
cessful. As there are no cell lines from marine organ-
isms, protein folding and binding could not be done in
a normal osmotic environment, and likely contributed
to these results. More importantly, the strong selective
pressure to correctly respond to extreme FuHC diversity
likely requires discriminatory abilities better than those
described in innate immune systems of other organ-
isms, including the vertebrates. As previously men-
tioned, it is unlikely that Botryllus contains the complex
recombinatorial machinery to create receptors specific
for each allele (Flajnik et al., 2003; Dehal et al., 2002),
and therefore effector specificity is not likely achieved
due to stoichiometric binding of two proteins, but rather
an overall avidity based on multiple interactions (e.g.,
those from multiple splice variants), which may be diffi-
cult to replicate in any expression system.
In summary, histocompatibility in Botryllus protects
an individual from invasion by parasitic stem cells, and
this system has evolved the capability to correctly differ-
entiate between hundreds of FuHC alleles. This discrim-
inatory ability is highly complex, perhaps more so than
vertebrate innate or NK-mediated immunity, but speci-
ficity is likely achieved by a nonrecombinatorial effector
system (Dehal et al., 2002; Azumi et al., 2003). While the
underlying mechanisms are not understood, the genetic
and functional data suggest that fester is a key player in
Botryllus histocompatibility and likely represents the
first allorecognition receptor identified outside of the
vertebrates. The origins and evolution of the remarkable
recognition abilities key to the function of the vertebrate
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schlosseri, with an experimentally accessible, highly
polymorphic allorecognition system, is poised to serve
as a model to explore these questions.
Experimental Procedures
Conditions for raising and crossing Botryllus schlosseri in the labo-
ratory, techniques for assaying phenotypic histocompatibility, ge-
netic and physical mapping of the FuHC locus, sequencing, DNA
and RNA isolation, cDNA synthesis, DNA and protein sequence anal-
ysis, and whole-mount in situ hybridization have been comprehen-
sively described elsewhere (De Tomaso and Weissman, 2003; De
Tomaso et al., 2005). Enzymes were from NEB (Beverly, MA). All
chemicals were purchased from Fisher (Pittsburgh, PA). Oligonucle-
otides were synthesized by Operon (Chatsworth, CA). Kits were
used for specific processes as described below.
Primers and RACE
RACE (Frohman et al., 1987) was done with the Smart II RACE Kit
(BD) with the following primers (50-30): Sense: GATATAACTGCGAGT
GTCAATTTGC; Sense Nest: TAACTGCGAGTGTCAATTTGCCTGTC;
Antisense: AAATTGTTTCCTCAGTATTCCACAC; Antisense Nest:
TTGTTTCCTCAGTATTCCACACAGC. Once the entire gene was
sequenced, the following two primers were designed from the 50
and 30 untranslated regions to amplify the entire gene: 50 UTR: AAA
GATAGTGCATCTGTTTCCATCCAA; 30 UTR: GCAGCTGCTTCGATT
TTCTTTCCTTGT.
The fester sequences have been deposited in GenBank with ac-
cession numbers DQ517888 for the membrane bound form and
DQ517889 for the secreted form.
Monoclonal Antibody Production
Monoclonal antibodies were raised to the fester gene product by
standard techniques (Harlow and Lane, 1988). A fester cDNA (con-
taining exons 1–8, 11) from a homozygous fester colony (haplotype
A) was cloned into a modified MSCV retroviral vector fused to a
cDNA for enhanced green fluorescent protein (EGFP; Clontech) at
the COOH tail of the fester message. Replication-defective retroviral
supernatants were prepared by transfecting 293 cells with the retro-
viral vector containing the fester-EGFP fusion gene and vectors for
the structural components of the virus (gag/pol and the viral enve-
lope isolated from vesicular stomatitis virus, VSVG). After transfec-
tion, the cells were incubated for 3 days at 32ºC. The virus-contain-
ing culture supernatants were harvested each day and combined
and stored at 280ºC.
Mouse-derived EL4 cell lines were infected with the virus contain-
ing the fester-EGFP fusion gene, and 3 days later, EGFP-positive
cells were sorted by FACS. Monoclonal antibodies generated
against EGFP and CD45 were used to verify expression at the cell
surface via confocal microscopy. These cells were then injected
into syngeneic mice, and hybridomas were formed and isolated by
standard methods (Harlow and Lane, 1988; Friedman et al., 1994).
Each hybridoma supernatant was screened for binding to the target
cells expressing the transgene versus the target cells expressing
vector alone and B. schlosseri homogenates via ELISA. Monoclonal
antibodies were purified further with Protein G (Pierce) and quanti-
fied by spectrophotometry.
Whole-Mount Immunohistochemistry
Samples were fixed in 1% w/v paraformaldehyde in filter-sterilized
seawater (FSSW) for 2 hr at 4ºC, rinsed in FSW for 5 min, and washed
in PBS (3 times, 10 min each). Samples were washed in PBTX (PBS
containing 1% TritonX-100) for 60 min at 4ºC followed by blocking in
PBTX containing 5% normal goat serum for 2 hr at 4ºC. Samples
were exposed to monoclonal antibodies generated against fester
at a dilution of 1:10 in PBTX containing 3% normal goat serum for
48 hr at 4ºC with rotation. Samples were washed in PBTX and ex-
posed to goat anti-mouse conjugated to Alexafluor 568 (Molecular
Probes, Eugene, OR) for 24 hr at 4ºC with rotation. Samples were
then mounted on slides with Vectashield and viewed on a Zeiss
LSM 310 multiphoton microscope. Nuclei were counterstained
with DAPI. As a control, a mAb raised to whole Botryllus blood cells,which binds to the tunic, was used (H. Boyd and I.L.W., unpublished
data).
Ampullaectomies
In order to induce regeneration of the vasculature during treatment
with siRNA, ampullectomies were performed on colonies prior to
histocompatibility assays. With a microscalpel, the entire peripheral
vasculature were dissected away from the zooids. Within 72 hr after
this procedure, new ampullae were generated and fully capable of
FuHC-based allorecognition reactions (A.V., S.V.N., K. Ishikuza,
I.L.W., and A.W.D., unpublished data).
Microinjection and mAb Interference
Microinjection of adult colonies was carried out as previously de-
scribed (Laird et al., 2005a). In brief, glass needles with a 50–60 mm
tip were produced on a micropipet puller (Sutter Instruments). Nee-
dles were loaded with 0.5–1.0 ml of either antibody (1 mg) or siRNA
(20 pmoles) in 0.1% phenol red and delivered through ampullar injec-
tion. For mAb inhibition experiments, both colonies were injected,
then placed in contact, and fusion/rejection was visually assayed.
RNAi Treatment
siRNAs to fester were generated with the commercially available
dicer enzyme kits (Gene Therapy Systems and Ambion). In brief,
for producing siRNAs to fester, PCR primers modified such that
they have a 20 bp T7 RNA polymerase promoter on the 50 and 30
end of the primers were designed to amplify out the entire extracel-
lular region of the fester gene. After amplification, the PCR product
was cleaned, and then double-stranded RNA was made via stan-
dard in vitro transcription techniques. The dsRNA was then digested
with dicer enzyme for 16 hr at 37ºC to convert dsRNA into 21 bp dou-
ble-stranded siRNA pieces. Digestion was confirmed by gel electro-
phoresis and then quantified by UV spectrophotometry. For knock-
out experiments, colonies growing on glass plates were removed
from the mariculture system and placed into a humid chamber. A
minimal amount of filter-sterilized sea water (50–150 ml) containing
25–100 pmols of siRNA was placed on top of the colony, such that
it is just submerged, and the colonies are incubated for 1 hr. This
was repeated for up to 7 days. Some colonies were also injected di-
rectly with 20 pmols/colony of siRNA before ampullectomy followed
by soaking with siRNA as described above.
Supplemental Data
One Supplemental Figure can be found with this article online at
http://www.immunity.com/cgi/content/full/25/1/163/DC1/.
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